Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
influenza vaccine
Biotech
FDA puts Novavax's phase 3 plan on hold for pair of vaccines
A phase 2 trial wrapped up in July 2023, with the “spontaneous” report of a patient developing motor neuropathy received last month.
James Waldron
Oct 16, 2024 9:10am
Pfizer, BioNTech combo mRNA shot latest to lose to flu strain B
Aug 16, 2024 8:25am
'Active' vaccine adjuvant boosts COVID, flu antibodies in mice
Jul 9, 2024 4:00am
CureVac gains $430M GSK vaccine contract, loses 30% of staff
Jul 3, 2024 5:00am
Blackstone bets $750M on Moderna's flu program
Mar 27, 2024 8:54am
Researchers find new flu antibodies that could improve vaccines
Dec 22, 2023 4:32pm
